{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:06:34Z","timestamp":1792598794451,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:00:00Z","timestamp":1773964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002386","name":"Cairo University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002386","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This study focuses on the preparation, characterization, and application of glycyrrhizic acid (GA)-modified chitosan\/selenium (Cs\/Se) nanocomposites (NC) for treating osteosarcoma cancer cells. The Cs-stabilized Se nanoparticles (Cs\/Se NPs) were synthesized through a chemical reduction method, where GA was added via a surface modification technique to enhance biocompatibility and targeting efficiency. Characterization of the GA-Cs\/Se NC and Cs\/Se NPs was performed using various techniques, including transmission electron microscopy (TEM), X-ray diffraction (XRD), Fourier-transform infrared spectroscopy (FTIR), and Zeta potential analysis. These analyses confirmed the successful formation of spherical NPs with a uniform size (100\u2013200\u00a0nm) and good distribution with appropriate surface modifications. GA-Cs\/Se NC exhibited potent cytotoxicity against MG-63 osteosarcoma cells, with an IC\n                    <jats:sub>50<\/jats:sub>\n                    of 76.65\u2009\u00b1\u20093.5\u00a0\u00b5g\/ml, whereas it had negligible effects on bone marrow stromal cells, confirming selective tumor targeting. Additionally, gene expression analysis revealed an 8.07-fold upregulation of the pro-apoptotic Bax and a 0.36-fold downregulation of the anti-apoptotic Bcl-2, indicating mitochondrial-mediated apoptosis. Moreover, qRT-PCR revealed a 7.13-fold increase in p53 expression, corroborating the induction of DNA damage-induced apoptotic pathways. The novel GA-Cs\/Se NC developed in this study uniquely integrates the ROS-mediated pro-apoptotic activity of Se NPs with the inhibitory and anti-inflammatory properties of GA, all within a Cs NPs matrix that improves stability, biocompatibility, and cellular uptake. This multifunctional design enables a synergistic mechanism combining oxidative stress induction with transcriptional modulation to selectively target and kill osteosarcoma cells while minimizing necrosis and inflammation.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-41099-w","type":"journal-article","created":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T14:44:31Z","timestamp":1774017871000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The cytotoxic effects of glycyrrhizic acid-modified chitosan\/selenium nanocomposite on osteosarcoma cancer cell line"],"prefix":"10.1038","volume":"16","author":[{"given":"Gamal","family":"El-ghannam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souad A.","family":"Elfeky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud T.","family":"Abo-Elfadl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Zedan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Moawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,20]]},"reference":[{"key":"41099_CR1","doi-asserted-by":"publisher","unstructured":"Elfeky, S. A., Elsayed, A., Moawad, M. & Ahmed, W. A. Hydroxyapatite nanocomposite as a potential agent in osteosarcoma PDT. Photodiagn. Photodyn. Ther. 32 https:\/\/doi.org\/10.1016\/j.pdpdt.2020.102056 (2020).","DOI":"10.1016\/j.pdpdt.2020.102056"},{"key":"41099_CR2","doi-asserted-by":"publisher","unstructured":"Qenawi, N., Tawfik, W., Abd-El, A. M., aziz & ElFeky, S. A. Innovative graphene oxide-folic acid-MoS2 nanocomposite for targeted near-infrared photothermal cancer therapy. Egypt J. Chem. https:\/\/doi.org\/10.21608\/ejchem.2025.358734.11274 (2025).","DOI":"10.21608\/ejchem.2025.358734.11274"},{"key":"41099_CR3","doi-asserted-by":"publisher","unstructured":"Alnasraui, A. H. F., Joe, I. H. & Al-Musawi, S. Design and synthesize of folate decorated Fe3O4@Au-DEX-CP nano formulation for targeted drug delivery in colorectal cancer therapy: In vitro and in vivo studies. J. Drug Deliv. Sci. Technol. 87, 104798. https:\/\/doi.org\/10.1016\/j.jddst.2023.104798 (2023).","DOI":"10.1016\/j.jddst.2023.104798"},{"key":"41099_CR4","doi-asserted-by":"publisher","unstructured":"Elfeky, S. A. & Qenawi, N. Nanoformulations Cancer Theranostics. https:\/\/doi.org\/10.1007\/16833_2024_446. (2024).","DOI":"10.1007\/16833_2024_446"},{"key":"41099_CR5","doi-asserted-by":"publisher","unstructured":"Allam, A., Tawfik, W., Abo-Elfadl, M. T., Fahmy, A. M. & Elfeky, S. A. Photoactive folic acid nanocomposite for targeted PDT of breast and liver cancer cell lines. Egypt J. Chem. https:\/\/doi.org\/10.21608\/ejchem.2025.358951.11281 (2025).","DOI":"10.21608\/ejchem.2025.358951.11281"},{"key":"41099_CR6","doi-asserted-by":"publisher","unstructured":"Sobeh, E. I., El-ghannam, G., Korany, R. M. S., Saleh, H. M. & Elfeky, S. A. Curcumin-loaded hydroxyapatite nanocomposite as a novel biocompatible shield for male Wistar rats from \u03b3-irradiation hazard. Chem. Biol. Interact. 370, 110328. https:\/\/doi.org\/10.1016\/j.cbi.2022.110328 (2023).","DOI":"10.1016\/j.cbi.2022.110328"},{"key":"41099_CR7","doi-asserted-by":"publisher","unstructured":"Netala, V. R. et al. Exploring the therapeutic potential of triterpenoid saponins from Gymnema sylvestre: Mechanistic insights into hepatoprotection, immunomodulation, anticancer activities, molecular docking, and pharmacokinetics. Heliyon 10 (23), e40850. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e40850 (2024).","DOI":"10.1016\/j.heliyon.2024.e40850"},{"key":"41099_CR8","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Advances in the roles of glycyrrhizic acid in cancer therapy. Front. Pharmacol. 14 https:\/\/doi.org\/10.3389\/fphar.2023.1265172 (2023).","DOI":"10.3389\/fphar.2023.1265172"},{"key":"41099_CR9","doi-asserted-by":"publisher","unstructured":"Cao, Z. et al. Glycyrrhizic acid rebalances mitochondrial dynamics to mitigate hepatotoxicity induced by triptolide. J. Funct. Foods. 113, 106006. https:\/\/doi.org\/10.1016\/j.jff.2024.106006 (2024).","DOI":"10.1016\/j.jff.2024.106006"},{"key":"41099_CR10","doi-asserted-by":"publisher","unstructured":"Filimonova, M. S. & Shimanovsky, N. L. Various formulations of glycyrrhizic acid and the possibility of their use in virus-associated and inflammatory diseases. Pharm. Chem. J. 57(4), 467\u2013475. https:\/\/doi.org\/10.1007\/s11094-023-02907-z (2023).","DOI":"10.1007\/s11094-023-02907-z"},{"key":"41099_CR11","doi-asserted-by":"publisher","unstructured":"Shaikh, S. et al. Biological insights and therapeutic potential of Glycyrrhiza uralensis and its bioactive compounds: an updated review. Arch. Pharm. Res. 47(12), 871\u2013892. https:\/\/doi.org\/10.1007\/s12272-024-01522-0 (2024).","DOI":"10.1007\/s12272-024-01522-0"},{"key":"41099_CR12","doi-asserted-by":"publisher","unstructured":"He, L., Zhang, L., Peng, Y. & He, Z. Selenium in cancer management: exploring the therapeutic potential. Front. Oncol. 14 https:\/\/doi.org\/10.3389\/fonc.2024.1490740 (2025).","DOI":"10.3389\/fonc.2024.1490740"},{"key":"41099_CR13","doi-asserted-by":"publisher","unstructured":"Karthik, K. K., Cheriyan, B. V., Rajeshkumar, S. & Gopalakrishnan, M. A review on selenium nanoparticles and their biomedical applications. Biomed. Technol. 6, 61\u201374. https:\/\/doi.org\/10.1016\/j.bmt.2023.12.001 (2024).","DOI":"10.1016\/j.bmt.2023.12.001"},{"key":"41099_CR14","doi-asserted-by":"publisher","unstructured":"Kudarha, R. et al. Recent advancements in selenium nanoconstructs as a potential carrier in cancer therapy. Nano-Struct. Nano-Objects. 40, 101399. https:\/\/doi.org\/10.1016\/j.nanoso.2024.101399 (2024).","DOI":"10.1016\/j.nanoso.2024.101399"},{"key":"41099_CR15","doi-asserted-by":"publisher","unstructured":"Pang, K. L. & Chin, K. Y. Emerging anticancer potentials of selenium on osteosarcoma. Int. J. Mol. Sci. 20, 5318. https:\/\/doi.org\/10.3390\/ijms20215318 (2019).","DOI":"10.3390\/ijms20215318"},{"key":"41099_CR16","doi-asserted-by":"publisher","unstructured":"El-ghannam, G., Moawad, M., Abo-Elfadl, M. T. & Elfeky, S. A. Beetroot extract@chitosan nanocomposite as a promising approach towards cancer therapy. Int. J. Biol. Macromol. 261, 129700. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.129700 (2024).","DOI":"10.1016\/j.ijbiomac.2024.129700"},{"key":"41099_CR17","doi-asserted-by":"publisher","unstructured":"Khurana, A., Tekula, S., Saifi, M. A., Venkatesh, P. & Godugu, C. Therapeutic applications of selenium nanoparticles. Biomed. Pharmacother. 111, 802\u2013812. https:\/\/doi.org\/10.1016\/j.biopha.2018.12.146 (2019).","DOI":"10.1016\/j.biopha.2018.12.146"},{"issue":"4","key":"41099_CR18","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s10904-018-0855-2","volume":"28","author":"MT Hasanin","year":"2018","unstructured":"Hasanin, M. T., Elfeky, S. A., Mohamed, M. B. & Amin, R. M. Production of well-dispersed aqueous cross-linked chitosan-based nanomaterials as alternative antimicrobial approach. J. Inorg. Organomet. Polym. Mater. 28 (4), 1502\u20131510. https:\/\/doi.org\/10.1007\/s10904-018-0855-2 (2018).","journal-title":"J. Inorg. Organomet. Polym. Mater."},{"key":"41099_CR19","doi-asserted-by":"publisher","unstructured":"Maleki Dana, P., Hallajzadeh, J., Asemi, Z., Mansournia, M. A. & Yousefi, B. Chitosan applications in studying and managing osteosarcoma. Int. J. Biol. Macromol. 169, 321\u2013329. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.12.058 (2021).","DOI":"10.1016\/j.ijbiomac.2020.12.058"},{"key":"41099_CR20","doi-asserted-by":"publisher","unstructured":"Kaur, K. et al. Mesoporous biosilica beads for controlled selenium nanoparticle delivery from collagen-chitosan scaffolds: promoting bone formation and suppressing prostate cancer growth. Adv. Nanobiomed. Res. 4 (12). https:\/\/doi.org\/10.1002\/anbr.202400110 (2024).","DOI":"10.1002\/anbr.202400110"},{"issue":"11","key":"41099_CR21","doi-asserted-by":"publisher","first-page":"3828","DOI":"10.1039\/D2BM02102A","volume":"11","author":"L He","year":"2023","unstructured":"He, L., Habibovic, P. & van Rijt, S. Selenium-incorporated mesoporous silica nanoparticles for osteosarcoma therapy. Biomater. Sci. 11 (11), 3828\u20133839. https:\/\/doi.org\/10.1039\/D2BM02102A (2023).","journal-title":"Biomater. Sci."},{"key":"41099_CR22","doi-asserted-by":"publisher","unstructured":"Shi, P. et al. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. J. Nanobiotechnol. 21 (1), 103. https:\/\/doi.org\/10.1186\/s12951-023-01826-1 (2023).","DOI":"10.1186\/s12951-023-01826-1"},{"key":"41099_CR23","doi-asserted-by":"publisher","unstructured":"Tang, H. et al. Apr., Preparation of glycyrrhizic acid-modified BSA-nanoparticles and evaluation of their hepatic cellular distribution. J. Pharm. Pharmacol. 76(4), 416\u2013425. https:\/\/doi.org\/10.1093\/jpp\/rgae019 (2024).","DOI":"10.1093\/jpp\/rgae019"},{"key":"41099_CR24","doi-asserted-by":"publisher","unstructured":"Stecanella, L. A. et al. Glycyrrhizic acid and its hydrolyzed metabolite 18\u03b2-glycyrrhetinic acid as specific ligands for targeting nanosystems in the treatment of liver cancer. Pharmaceutics. 13 (11), 1792. https:\/\/doi.org\/10.3390\/pharmaceutics13111792 (2021).","DOI":"10.3390\/pharmaceutics13111792"},{"key":"41099_CR25","doi-asserted-by":"publisher","unstructured":"Ramachandran, T. et al. Synthesis and structural characterization of selenium nanoparticles\u2013Bacillus sp. MKUST-01 exopolysaccharide (Se NPs\u2013EPS) conjugate for biomedical applications. Biomedicines. 11(9), 2520. https:\/\/doi.org\/10.3390\/biomedicines11092520 (2023).","DOI":"10.3390\/biomedicines11092520"},{"key":"41099_CR26","doi-asserted-by":"publisher","unstructured":"Cheng, M. et al. Synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and its inhibition of liver cancer characteristics in vitro and in vivo, Mar. Drugs 11(9), 3517\u20133536. https:\/\/doi.org\/10.3390\/md11093517 (2013).","DOI":"10.3390\/md11093517"},{"key":"41099_CR27","doi-asserted-by":"publisher","unstructured":"Gosala, R., Subramanian, R. & Subramanian, B. Modulating drug delivery with nano-selenium capped by chitosan reverse micelles for anticancer potential. J. Drug Deliv Sci. Technol. 108, 106860. https:\/\/doi.org\/10.1016\/j.jddst.2025.106860 (2025).","DOI":"10.1016\/j.jddst.2025.106860"},{"issue":"5","key":"41099_CR28","first-page":"5175","volume":"8","author":"SQ He","year":"2015","unstructured":"He, S. Q., Gao, M., Fu, Y. F. & Zhang, Y. N. Glycyrrhizic acid inhibits leukemia cell growth and migration via blocking AKT\/mTOR\/STAT3 signaling. Int. J. Clin. Exp. Pathol. 8 (5), 5175\u20135181 (2015).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"41099_CR29","doi-asserted-by":"publisher","unstructured":"Maridas, D. E., Rendina-Ruedy, E., Le, P. T. & Rosen, C. J. Isolation, culture, and differentiation of bone marrow stromal cells and osteoclast progenitors from mice. J. Vis. Exp. https:\/\/doi.org\/10.3791\/56750 (2018).","DOI":"10.3791\/56750"},{"key":"41099_CR30","doi-asserted-by":"publisher","unstructured":"Nga, N. T. H., Ngoc, T. T. B., Trinh, N. T. M., Thuoc, T. L. & Thao, D. T. P. Optimization and application of MTT assay in determining density of suspension cells. Anal. Biochem. 610, 113937. https:\/\/doi.org\/10.1016\/j.ab.2020.113937 (2020).","DOI":"10.1016\/j.ab.2020.113937"},{"key":"41099_CR31","doi-asserted-by":"publisher","unstructured":"Leite, M., Quinta-Costa, M., Leite, P. S. & Guimar\u00e3es, J. E. Critical evaluation of techniques to detect and measure cell death\u2014Study in a model of UV radiation of the leukaemic cell line HL60. Anal. Cell. Pathol. 19, 3\u20134. https:\/\/doi.org\/10.1155\/1999\/176515 (1999).","DOI":"10.1155\/1999\/176515"},{"key":"41099_CR32","doi-asserted-by":"publisher","unstructured":"Mitupatum, T. et al. mRNA expression of Bax, Bcl-2, p53, Cathepsin B, Caspase-3 and Caspase-9 in the HepG2 cell line following induction by a novel monoclonal Ab Hep88 mAb: Cross-talk for paraptosis and apoptosis. Asian Pac. J. Cancer Prev. 17(2), 703\u2013712. https:\/\/doi.org\/10.7314\/APJCP.2016.17.2.703 (2016).","DOI":"10.7314\/APJCP.2016.17.2.703"},{"key":"41099_CR33","doi-asserted-by":"publisher","unstructured":"Mohammadian, J., Sabzichi, M., Molavi, O., Shanehbandi, D. & Samadi, N. Combined treatment with stattic and docetaxel alters the Bax\/Bcl-2 gene expression ratio in human prostate cancer cells. Asian Pac. J. Cancer Prev. 17 (11), 5031\u20135035. https:\/\/doi.org\/10.22034\/APJCP.2016.17.11.5031 (2016).","DOI":"10.22034\/APJCP.2016.17.11.5031"},{"key":"41099_CR34","doi-asserted-by":"publisher","unstructured":"Abaidullah, N., Muhammad, K. & Waheed, Y. Delving into nanoparticle systems for enhanced drug delivery technologies. AAPS PharmSciTech. 26 (3), 74. https:\/\/doi.org\/10.1208\/s12249-025-03063-1 (2025).","DOI":"10.1208\/s12249-025-03063-1"},{"key":"41099_CR35","doi-asserted-by":"publisher","unstructured":"Yusuf, A., Almotairy, A. R. Z., Henidi, H., Alshehri, O. Y. & Aldughaim, M. S. Nanoparticles as drug delivery systems: A review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems. Polymers (Basel). 15(7), 1596. https:\/\/doi.org\/10.3390\/polym15071596 (2023).","DOI":"10.3390\/polym15071596"},{"key":"41099_CR36","doi-asserted-by":"publisher","unstructured":"Zhang, S. & Wang, C. Precise analysis of nanoparticle size distribution in TEM image. Methods Protoc. 6 (4), 63. https:\/\/doi.org\/10.3390\/mps6040063 (2023).","DOI":"10.3390\/mps6040063"},{"key":"41099_CR37","doi-asserted-by":"publisher","unstructured":"Lunkov, A. et al. Synthesis of selenium nanoparticles modified by quaternary chitosan covalently bonded with gallic acid. Polym. (Basel). 15 (9), 2123. https:\/\/doi.org\/10.3390\/polym15092123 (2023).","DOI":"10.3390\/polym15092123"},{"key":"41099_CR38","doi-asserted-by":"publisher","unstructured":"Karthick Raja Namasivayam, S. et al. Green synthesis of chitosan\u2013selenium bionanocomposite with high biocompatibility and its marked impact on Las B and RhII genes expression in Pseudomonas aeruginosa. J. Inorg. Organomet Polym. Mater. 32(11), 4186\u20134203. https:\/\/doi.org\/10.1007\/s10904-022-02431-9 (2022).","DOI":"10.1007\/s10904-022-02431-9"},{"key":"41099_CR39","doi-asserted-by":"publisher","unstructured":"Habeeb, Z. A., Jameel, S. K. & Ahmed, M. E. Synthesis, characterization, and cytotoxic evaluation of selenium nanoparticles. Biomed. Pharmacol. J. 18(1), 909\u2013919. https:\/\/doi.org\/10.13005\/bpj\/3139 (2025).","DOI":"10.13005\/bpj\/3139"},{"key":"41099_CR40","unstructured":"Segneanu, A. E., Gozescu, I., Dabici, A., Sfirloaga, P. & Szabadai, Z. Organic Compounds FT-IR Spectroscopy. https:\/\/www.intechopen.com."},{"key":"41099_CR41","doi-asserted-by":"publisher","unstructured":"Zhang, Q., Huang, J., Wang, K. & Huang, W. Recent Structural Engineering of Polymer Semiconductors Incorporating Hydrogen Bonds. Adv. Mater. 34 (26). https:\/\/doi.org\/10.1002\/adma.202110639 (2022).","DOI":"10.1002\/adma.202110639"},{"key":"41099_CR42","unstructured":"Textmap, W. Organic chemistry. https:\/\/LibreTexts.org."},{"key":"41099_CR43","doi-asserted-by":"publisher","unstructured":"Coates, J. Interpretation of infrared spectra, a practical approach. In Encyclopedia of Analytical Chemistry. https:\/\/doi.org\/10.1002\/9780470027318.a5606 (Wiley, 2000).","DOI":"10.1002\/9780470027318.a5606"},{"key":"41099_CR44","doi-asserted-by":"publisher","unstructured":"Tiama, T. M., Ismail, A. M., Elhaes, H. & Ibrahim, M. A. Structural and spectroscopic studies for chitosan\/Fe3O4 nanocomposites as glycine biosensors. Biointerface Res. Appl. Chem. 13(6). https:\/\/doi.org\/10.33263\/BRIAC136.547 (2023).","DOI":"10.33263\/BRIAC136.547"},{"key":"41099_CR45","doi-asserted-by":"publisher","unstructured":"Bai, L. et al. Antioxidant activities of natural polysaccharides and their derivatives for biomedical and medicinal applications. Antioxidants. 11 (12), 2491. https:\/\/doi.org\/10.3390\/antiox11122491 (2022).","DOI":"10.3390\/antiox11122491"},{"key":"41099_CR46","doi-asserted-by":"publisher","unstructured":"Zhai, X. et al. Antioxidant capacities of the selenium nanoparticles stabilized by chitosan. J. Nanobiotechnol. 15 (1), 4. https:\/\/doi.org\/10.1186\/s12951-016-0243-4 (2017).","DOI":"10.1186\/s12951-016-0243-4"},{"key":"41099_CR47","doi-asserted-by":"publisher","unstructured":"Sam, S. et al. Green synthesis and optimization of selenium nanoparticles using chitosan or cationic cellulose nanofibers. Cellulose. 32 (2), 919\u2013940. https:\/\/doi.org\/10.1007\/s10570-024-06341-6 (2025).","DOI":"10.1007\/s10570-024-06341-6"},{"key":"41099_CR48","doi-asserted-by":"publisher","unstructured":"Abdelhamid, A. E., Ahmed, E. H., Awad, H. M. & Ayoub, M. M. H. Synthesis and cytotoxic activities of selenium nanoparticles incorporated nano-chitosan. Polym. Bull. 81 (2), 1421\u20131437. https:\/\/doi.org\/10.1007\/s00289-023-04768-8 (2024).","DOI":"10.1007\/s00289-023-04768-8"},{"key":"41099_CR49","doi-asserted-by":"publisher","unstructured":"Mahmood, R. I. et al. Biogenic synthesized selenium nanoparticles combined chitosan nanoparticles controlled lung cancer growth via ROS generation and mitochondrial damage pathway. Nanotechnol. Rev. 14 (1). https:\/\/doi.org\/10.1515\/ntrev-2025-0142 (2025).","DOI":"10.1515\/ntrev-2025-0142"},{"issue":"9","key":"41099_CR50","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1039\/C8MD00288F","volume":"9","author":"W Liu","year":"2018","unstructured":"Liu, W. et al. Glycyrrhizic acid from licorice down-regulates inflammatory responses via blocking MAPK and PI3K\/Akt-dependent NF-\u03baB signalling pathways in TPA-induced skin inflammation. Medchemcomm. 9 (9), 1502\u20131510. https:\/\/doi.org\/10.1039\/C8MD00288F (2018).","journal-title":"Medchemcomm"},{"key":"41099_CR51","doi-asserted-by":"publisher","unstructured":"Seaf Elnasr, T. A. et al. Chitosan\/Selenium@Olive oil nanocomplex targeted therapy for multiple cancers. J. Polym. Environ. 32 (2), 658\u2013671. https:\/\/doi.org\/10.1007\/s10924-023-02975-y (2024).","DOI":"10.1007\/s10924-023-02975-y"},{"key":"41099_CR52","doi-asserted-by":"publisher","unstructured":"Mostafa, O., Saleh, H. M., Salaheldin, T. A., Ibrahim, A. K. & Elfeky, S. A. Fluorescein\/gold nanoparticles conjugated EGFR antibody for imaging and P53 upregulation in hamster mucosal cells carcinoma. J. Drug Deliv. Sci. Technol. 76 https:\/\/doi.org\/10.1016\/j.jddst.2022.103293 (2022).","DOI":"10.1016\/j.jddst.2022.103293"},{"key":"41099_CR53","doi-asserted-by":"publisher","unstructured":"Tuli, H. S. et al. Licorice (Glycyrrhiza glabra L.)-derived phytochemicals target multiple signaling pathways to confer oncopreventive and oncotherapeutic effects. Onco Targets Ther. 15, 1419\u20131448. https:\/\/doi.org\/10.2147\/OTT.S366630 (2022).","DOI":"10.2147\/OTT.S366630"},{"key":"41099_CR54","doi-asserted-by":"publisher","unstructured":"Sun, S. J. et al. Selenium-modified chitosan induces HepG2 cell apoptosis and differential protein analysis. Cancer Manag. Res. 14, 3335\u20133345. https:\/\/doi.org\/10.2147\/CMAR.S382546 (2022).","DOI":"10.2147\/CMAR.S382546"},{"key":"41099_CR55","doi-asserted-by":"publisher","unstructured":"Wang, H. et al. Glycyrrhizic acid inhibits proliferation of gastric cancer cells by inducing cell cycle arrest and apoptosis, Cancer Manag. Res. 12, 2853\u20132861. https:\/\/doi.org\/10.2147\/CMAR.S244481 (2020).","DOI":"10.2147\/CMAR.S244481"},{"key":"41099_CR56","doi-asserted-by":"publisher","unstructured":"Tian, J., Wei, X., Zhang, W. & Xu, A. Effects of selenium nanoparticles combined with radiotherapy on lung cancer cells. Front. Bioeng. Biotechnol. 8 https:\/\/doi.org\/10.3389\/fbioe.2020.598997 (2020).","DOI":"10.3389\/fbioe.2020.598997"},{"key":"41099_CR57","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1398844\/v1","author":"KRN Selvaraj","year":"2022","unstructured":"Selvaraj, K. R. N. et al. Green synthesis of Chitosan - Selenium bionanocomposite with high biocompatibility and its marked impact on Las B and RhII genes expression in Pseudomonas aeruginosa. https:\/\/doi.org\/10.21203\/rs.3.rs-1398844\/v1 (2022).","journal-title":"Mar. 02"},{"key":"41099_CR58","doi-asserted-by":"publisher","unstructured":"He, B. et al. Optimized synthesis of glycyrrhetinic acid-modified chitosan 5-fluorouracil nanoparticles and their characteristics. Int. J. Nanomed. https:\/\/doi.org\/10.2147\/IJN.S55255 (2014).","DOI":"10.2147\/IJN.S55255"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41099-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41099-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:34:15Z","timestamp":1781642055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-41099-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["41099"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-41099-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]},"assertion":[{"value":"10 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9677"}}